This video is sponsored by the Duke Clinical Medical Series.
The moderator, Peter Berger, MD, has indicated that he receives research/grant support
from Aventis, Conor, Guilford, Lumen, and Velocimed. Dr. Berger is also a member of an
advisory board for Genentech and Cordis/Johnson & Johnson; he has spoken at scientific
symposia for Aventis, Bristol-Myers Squibb, Genentech, and Guilford. Dr. Berger also
serves as Medical Director and has equity with Lumen, Inc.
The guest faculty, Robert Harrington, MD, has indicated that he received research/grant
support from Aventis, BI, Centocor, Eli Lilly, Genentech, Guilford, Merck, Millennium,
Schering-Plough, and The Medicines Company.
|
|